News
InvestorsHub on MSN19m
GSK shares rise after FDA grants priority review for oral gonorrhea antibioticGSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback